Technologies Ahead of Their Time. The Innovative Development Path of the Russian Pharmaceutical Industry

In accordance with the Russian government’s Unified Plan for Achieving National Development Goals by 2030 and 2036, the state’s strategic priorities include ensuring economic growth, increasing the life expectancy of the population, and achieving technological sovereignty. One key condition for accomplishing this goal is the innovative development of the pharmaceutical industry. Such development should focus on the high-tech production of drugs, especially vital and essential drugs, high-quality import substitution, and reducing dependence on foreign drug supplies. The plan pays particular attention to advanced orphan drugs and ensuring a greater personalized approach in the development of pharmaceutical products, including in an effort to expand the capabilities of small-scale drug production. The creation of effective generic drugs is another important component in the development of the Russian pharmaceutical industry and will have a positive impact on the availability of medical care to the population. What national and federal projects contribute to the innovative development of the pharmaceutical industry in Russia? How do the efforts of the government, medical science, and business community impact the effectiveness of drug import substitution and the development of advanced pharmaceutical products? What measures are needed to create conditions for the full cycle of drug development? What innovative technologies play the greatest role in the process of creating pharmaceutical products? How can we predict demand for drugs in the future?